Atlas Trials

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis

Clinical trial NCT01344083 · COMPLETED

Trial details

NCT number
NCT01344083
Sponsor
Laboratoires Thea
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Seasonal Allergic Conjunctivitis
Start date
2011-04-01
Primary completion
2012-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.